ATC Group: M03AC11 Cisatracurium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M03AC11 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M03 Muscle relaxants
3 M03A Muscle relaxants, peripherally acting agents
4 M03AC Other quaternary ammonium compounds
5 M03AC11 Cisatracurium

Active ingredients in M03AC11

Active Ingredient Description
Cisatracurium

Cisatracurium is an intermediate-duration, non-depolarising benzylisoquinolinium skeletal muscle relaxant. Cisatracurium binds to cholinergic receptors on the motor end-plate to antagonise the action of acetylcholine, resulting in a competitive block of neuromuscular transmission. This action is readily reversed by anti-cholinesterase agents such as neostigmine or edrophonium.

Related product monographs

Title Information Source Document Type  
CISATRACURIUM Solution for injection/infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NIMBEX Solution for injection / infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.